rs111924728
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003482.4(KMT2D):c.5217C>T(p.Gly1739Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00446 in 1,613,946 control chromosomes in the GnomAD database, including 176 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.018   (  77   hom.,  cov: 32) 
 Exomes 𝑓:  0.0030   (  99   hom.  ) 
Consequence
 KMT2D
NM_003482.4 synonymous
NM_003482.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.32  
Publications
5 publications found 
Genes affected
 KMT2D  (HGNC:7133):  (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010] 
KMT2D Gene-Disease associations (from GenCC):
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77). 
BP6
Variant 12-49043970-G-A is Benign according to our data. Variant chr12-49043970-G-A is described in ClinVar as Benign. ClinVar VariationId is 94226.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=1.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0595  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0184  AC: 2803AN: 152140Hom.:  77  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2803
AN: 
152140
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00654  AC: 1631AN: 249238 AF XY:  0.00590   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1631
AN: 
249238
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00300  AC: 4389AN: 1461688Hom.:  99  Cov.: 32 AF XY:  0.00308  AC XY: 2237AN XY: 727122 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
4389
AN: 
1461688
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2237
AN XY: 
727122
show subpopulations 
African (AFR) 
 AF: 
AC: 
2336
AN: 
33480
American (AMR) 
 AF: 
AC: 
195
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
1092
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
53378
Middle Eastern (MID) 
 AF: 
AC: 
46
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
338
AN: 
1111870
Other (OTH) 
 AF: 
AC: 
381
AN: 
60374
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.480 
Heterozygous variant carriers
 0 
 266 
 532 
 799 
 1065 
 1331 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 104 
 208 
 312 
 416 
 520 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0185  AC: 2810AN: 152258Hom.:  77  Cov.: 32 AF XY:  0.0182  AC XY: 1356AN XY: 74442 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2810
AN: 
152258
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1356
AN XY: 
74442
show subpopulations 
African (AFR) 
 AF: 
AC: 
2553
AN: 
41540
American (AMR) 
 AF: 
AC: 
160
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5186
South Asian (SAS) 
 AF: 
AC: 
52
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10598
Middle Eastern (MID) 
 AF: 
AC: 
5
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
16
AN: 
68020
Other (OTH) 
 AF: 
AC: 
23
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.489 
Heterozygous variant carriers
 0 
 127 
 254 
 380 
 507 
 634 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 30 
 60 
 90 
 120 
 150 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
48
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:8 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:4 
Jul 06, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 18, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 22, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:2 
Oct 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Kabuki syndrome    Benign:1 
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Kabuki syndrome 1    Benign:1 
Sep 20, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.